Patient Perceptions Around Quality of Care Through Telemedicine in Neuro-Oncology

Launched by M.D. ANDERSON CANCER CENTER · Aug 2, 2021

Keywords

ClinConnect Summary

This clinical trial is looking at how patients with brain tumors feel about the quality of care they receive through telemedicine, which is a way for doctors and patients to connect using technology instead of meeting in person. By gathering feedback through questionnaires from patients who have had appointments for their brain cancer at the MD Anderson Cancer Center, the study aims to understand how telemedicine can be improved to better serve these patients' needs.

To participate in this trial, you need to be an established patient with a central nervous system tumor, which includes various types of brain tumors. You should have had a follow-up appointment with the Neuro-Oncology team, either in person or through telemedicine. However, if your appointment required a language translator, was just a phone call, or was your first visit, you wouldn’t be eligible to join. If you decide to participate, you can expect to answer questions about your experiences with your care, which can help improve services for others in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients with a CNS tumors: this includes patients with primary brain tumors, brain metastases, and leptomeningeal disease
• • Established patients with a follow up encounter with Neuro-Oncology at the Brain and Spine Center at the University of Texas MD Anderson Cancer Center; this encounter can be
• • An in-person visit
• • A telemedicine appointment
• Exclusion Criteria:
• • Encounter occurred with the assistance of official language translation support
• • Patients with telephone encounters (without interactive video)
• • New patient or consult visits
• • Neither patient nor caregiver present during the visit are available or able to answer survey questions